The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex multi-step synthetic process. Early routes focused on peptide portion coupling, utilizing solid-phase https://luluukja114438.blogitright.com/41047079/production-and-research-applications-of-retatrutide